Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice

References

• Michielsens CAJ, van Muijen ME, Verhoef LM, et al. Dose tapering of biologics in patients with psoriasis: a scoping review. Drugs. 2021;81(3):349–366.
   PubMed Web of Science ®Google Scholar
• Atalay S, van den Reek J, Otero ME, et al. Health economic consequences of a tightly controlled dose reduction strategy for adalimumab, etanercept and ustekinumab compared with standard psoriasis care: a cost-utility analysis of the CONDOR study. Acta Derm Venereol. 2020;100(19):adv00340.
   PubMedGoogle Scholar
• van Muijen ME, van der Schoot LS, van den Reek J, et al. Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide. Arch Dermatol Res. 2022;314(7):687–695.
   PubMed Web of Science ®Google Scholar
• Aubert H, Mahe E, Fougerousse AC, et al. Dose spacing and reduction strategies in biotherapies for stable, clear or almost clear psoriasis: a survey of practices in France. Ann Dermatol Venereol. 2022;149(1):68–70.
   PubMed Web of Science ®Google Scholar
• Aubert H, Arlegui H, De Rycke Y, et al. Biologic tapering for patients with psoriasis with low disease activity: data from the french PsoBioTeq registry. Br J Dermatol. 2023;188(1):150–152.
   PubMed Web of Science ®Google Scholar
• van Muijen ME, van der Schoot LS, Bovenschen HJ, et al. Dosisvermindering van biologics voor psoriasis. Nederlands Tijdschrift Voor Dermatologie en Venereologie. 2021;31(1):22–26.
   Google Scholar
• Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465.
   PubMed Web of Science ®Google Scholar
• Bauer MS, Kirchner J. Implementation science: what is it and why should I care? Psychiatry Res. 2020; 283:112376.
   PubMed Web of Science ®Google Scholar
• Atalay S, van der Schoot LS, Vandermaesen L, et al. Evaluation of a one-step dose reduction strategy of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily practice. Acta Derm Venereol. 2021 May 25;101(5):adv00463.
   PubMedGoogle Scholar
• Stetler CB, Mittman BS, Francis J. Overview of the VA quality enhancement research initiative (QUERI) and QUERI theme articles: QUERI series. Implement Sci. 2008; 3:8.
   PubMed Web of Science ®Google Scholar
• Pearson N, Naylor PJ, Ashe MC, et al. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020;6(1):167.
   PubMedGoogle Scholar
• Atkins L, Francis J, Islam R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.
   Google Scholar
• Flottorp SA, Oxman AD, Krause J, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8:35.
   PubMed Web of Science ®Google Scholar
• Kitson AL, Harvey G. Methods to succeed in effective knowledge translation in clinical practice. J Nurs Scholarsh. 2016;48(3):294–302.
   PubMed Web of Science ®Google Scholar
• Milat AJ, Li B. Narrative review of frameworks for translating research evidence into policy and practice. Public Health Res Pract. 2017;27(1):2711704.
   Google Scholar
• Damschroder LJ, Reardon CM, Opra Widerquist MA, et al. Conceptualizing outcomes for use with the consolidated framework for implementation research (CFIR): the CFIR outcomes addendum. Implement Sci. 2022;17(1):7.
   Web of Science ®Google Scholar
• Pinnock H, Barwick M, Carpenter CR, et al. Standards for reporting implementation studies (StaRI) statement. BMJ. 2017;356:i6795.
   PubMedGoogle Scholar
• O”Brien BC, Harris IB, Beckman TJ, et al. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–1251.
   PubMed Web of Science ®Google Scholar
• Atalay S, van den Reek J, van Vugt LJ, et al. Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial. BMC Dermatol. 2017;17(1):6.
   PubMedGoogle Scholar
• Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing’) to improve clinical decision making. JAMA. 1990; 263(4):549–556.
   PubMed Web of Science ®Google Scholar
• McKay H, Naylor PJ, Lau E, et al. Implementation and scale-up of physical activity and behavioural nutrition interventions: an evaluation roadmap. Int J Behav Nutr Phys Act. 2019;16(1):102.
   PubMed Web of Science ®Google Scholar
• Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006; 3(2):77–101.
   Google Scholar
• Dures E, Taylor J, Shepperd S, et al. Mixed methods study of clinicians” perspectives on barriers to implementation of treat to target in psoriatic arthritis. Ann Rheum Dis. 2020;79(8):1031–1036.
   PubMed Web of Science ®Google Scholar
• Lesuis N, Verhoef LM, Nieboer LM, et al. Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study. Scand J Rheumatol. 2017;46(2):152–155.
   PubMed Web of Science ®Google Scholar
• Atalay S, van den Reek JMPA, den Broeder AA, et al. Comparison of tightly controlled dose reduction of biologics with usual care for patients with psoriasis: a randomized clinical trial. JAMA Dermatol. 2020;156(4):393–400.
   PubMed Web of Science ®Google Scholar
• van der Schoot LS, Atalay S, Otero ME, et al. Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab. Br J Dermatol. 2022;187(6):1028–1030.
   PubMed Web of Science ®Google Scholar
• Kitzinger J. Qualitative research. Introducing focus groups. BMJ. 1995;311(7000):299–302.
   PubMed Web of Science ®Google Scholar